CODX

0.278

0.79% -0.0022

Handel nachbörslich: .28 0.002 +0.72%

Co Diagnostics Inc (CODX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.2802

Offen:

$0.286

24-Stunden-Volumen:

165.96K

Relative Volume:

0.46

Marktkapitalisierung:

$9.83M

Einnahmen:

$7.11M

Nettoeinkommen (Verlust:

$-41.28M

KGV:

-0.2014

EPS:

-1.38

Netto-Cashflow:

$-26.84M

1W Leistung:

+4.71%

1M Leistung:

+8.81%

6M Leistung:

-62.93%

1J Leistung:

-77.94%

1-Tages-Spanne:

$0.2702

$0.30

1-Wochen-Bereich:

$0.2559

$0.30

52-Wochen-Spanne:

$0.2275

$2.2299

Co Diagnostics Inc Stock (CODX) Company Profile

Firmenname

Co Diagnostics Inc

Sektor

Healthcare (1166)

Branche

Medical Devices (148)

Telefon

(801) 278-9769

Adresse

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Mitarbeiter

132

Twitter

@Co_Diagnostics

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

CODX's Discussions on Twitter

Vergleichen Sie CODX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CODX Co Diagnostics Inc	0.278	9.83M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	136.26	233.36B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	104.78	147.06B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	396.74	145.64B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	88.75	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	77.18	44.46B	5.54B	4.18B	623.10M	7.00

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-08-12	Herabstufung	Sidoti	Buy → Neutral
2021-12-29	Eingeleitet	Sidoti	Buy
2021-03-29	Herabstufung	Maxim Group	Buy → Hold
2020-05-20	Hochstufung	Maxim Group	Hold → Buy
2020-05-18	Bestätigt	H.C. Wainwright	Buy
2020-03-09	Bestätigt	H.C. Wainwright	Buy
2020-03-03	Herabstufung	Maxim Group	Buy → Hold

Alle ansehen

Co Diagnostics Inc Aktie (CODX) Neueste Nachrichten

Jun 07, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire

Jun 07, 2025

CODX INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm - ACCESS Newswire

Jun 07, 2025

Jun 06, 2025

Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Up 19.5% in May - Defense World

Jun 06, 2025

Jun 04, 2025

Co-Diagnostics completes first FDA 510(k) application for Co-Dx PCR Pro - TipRanks

Jun 04, 2025

May 29, 2025

Co-Diagnostics Holds Annual Shareholders Meeting - TipRanks

May 29, 2025

May 21, 2025

Co-Diagnostics stock hits 52-week low at $0.27 amid market challenges - Investing.com Australia

May 21, 2025

May 16, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference | CODX Stock News - GuruFocus

May 14, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - The Manila Times

May 14, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Capital Inaugural Global Conference on May 14, 2025 - Nasdaq

May 14, 2025

Co-Diagnostics Unveils Next-Gen PCR Testing Platform to Elite Institutional Investors - Stock Titan

May 14, 2025

May 10, 2025

Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025

May 09, 2025

Earnings call transcript: Co-Diagnostics Q1 2025 shows improved EPS and revenue decline - Investing.com Nigeria

May 09, 2025